| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/01/2006 | EP1339710B1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
| 03/01/2006 | EP1324774B1 Use of a ppar delta activator for treating inflammatory conditions |
| 03/01/2006 | EP1319007B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/01/2006 | EP1311507B1 Fused pyrazole derivatives being protein kinase inhibitors |
| 03/01/2006 | EP1296667B1 Compounds for preventing and/or treating urticaria |
| 03/01/2006 | EP1206471B1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 03/01/2006 | EP1143983B1 Spray delivery of cells |
| 03/01/2006 | EP1123082B1 Preparations for topical application of substances having antiandrogenic effect |
| 03/01/2006 | EP0998569B1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells |
| 03/01/2006 | EP0980243B1 Use of high dose retinoids for the treatment of photodamaged skin |
| 03/01/2006 | CN1741820A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 03/01/2006 | CN1739797A Compound recipe for replenishing collagen |
| 03/01/2006 | CN1739792A Externally applied liquid prepn of recombinant human granulocyte-macrophage colony stimulating factor |
| 03/01/2006 | CN1739788A Modulation of TRIP-BR function and method of treating proliferative disorders |
| 03/01/2006 | CN1739787A Orally administered peptides to ameliorate atherosclerosis |
| 03/01/2006 | CN1739777A Women's lotion of flowers |
| 03/01/2006 | CN1739775A Spray for treating burns, scalds and chronic ulcer and its prepn |
| 03/01/2006 | CN1739774A Spot eliminating and youthful looks preserving capsule |
| 03/01/2006 | CN1739753A Psoriasis treating Chinese medicine prepn and its pren process |
| 03/01/2006 | CN1739719A Dermatosis treating Chinese medicine prepn |
| 03/01/2006 | CN1739706A Tongue dropping medicine pill for diminishing inflammation and detoxicating |
| 03/01/2006 | CN1739697A Externally applied ointment for treating burns and scalds |
| 03/01/2006 | CN1739684A Dermatosis eliminating medicine |
| 03/01/2006 | CN1739665A Method of preparing active medicinal matter of lignin from broad-leaved tree and its use |
| 03/01/2006 | CN1739662A Medicine for treating traumatic injury and its prepn |
| 03/01/2006 | CN1739640A Beautifying prepn with also dermatosis treating function and its prepn |
| 03/01/2006 | CN1739632A Antiphlogistic bezoar dripping pill and its prepn process |
| 03/01/2006 | CN1739627A Scald treating liniment |
| 03/01/2006 | CN1739587A Burn and scald ointment and its prepn |
| 03/01/2006 | CN1739563A Medicated cream and its prepn process |
| 03/01/2006 | CN1739547A Acne treating ointment |
| 03/01/2006 | CN1739494A Orally taken self-microemulsified concentrate of all-trans vitamin A acid |
| 03/01/2006 | CN1243773C Process for cross-linking hyaluronic acid to polymers |
| 03/01/2006 | CN1243753C Substituted 3,4-dihydro-pyrimido[1,2-A] pyrimidines and 3,4-dihydropyrazino [1,2-A] pyrimidines |
| 03/01/2006 | CN1243746C Heterocyclic compound inhibiting angiogenesis |
| 03/01/2006 | CN1243724C Amide derivatives which are useful as cell factor inhibitors |
| 03/01/2006 | CN1243560C Medicine for treating dermatosis and its preparation method |
| 03/01/2006 | CN1243553C Externally applied medicine for hemostasis and trauma healing and promoting reunion of fractured bones |
| 03/01/2006 | CN1243551C Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response |
| 03/01/2006 | CN1243550C Pharmaceutical compositions and uses for androst-5-ene-3beta, 17 beta-diol and use thereof |
| 03/01/2006 | CN1243546C Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 03/01/2006 | CN1243537C Use of composition containing at least one oxidative sensitive hydrophilic active ingredient through at least one maleic anhydride copolymer stabilization at cosmetic and /or skin |
| 03/01/2006 | CN1243536C Use of sphingomyelin for preparing compositions to increase the levels of skin and mucosal ceramides, and dermatological and cosmetic composition |
| 02/28/2006 | US7005516 Derivatives of monosaccharides as cell adhesion inhibitors |
| 02/28/2006 | US7005434 Compounds and uses thereof |
| 02/28/2006 | US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/28/2006 | US7005422 Derivatives of monosaccharides as cell adhesion inhibitors |
| 02/28/2006 | US7005415 Wherein the DNA synthesis promoting activity of the heparin-binding protein is increased by the covalently bonded sugar chain which can be heparan sulfate; improved in vivo stabilities such as acid resistance and alkali resistance |
| 02/28/2006 | US7005148 Aging resistance |
| 02/23/2006 | WO2006019169A1 3-epivitamin d3 derivative and therapeutic agent containing the same |
| 02/23/2006 | WO2006019114A1 Skin-lightening agent containing polyphenol compound |
| 02/23/2006 | WO2006018732A1 Androgen modulators |
| 02/23/2006 | WO2006018326A1 Novel biaromatic compounds that activate ppar type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 02/23/2006 | WO2006018325A1 Novel biaromatic compounds which activate receptors of ppar type and their use in cosmetic or pharmaceutical compositions |
| 02/23/2006 | WO2006018185A2 Dihydropteridinones for the treatment of cancer diseases |
| 02/23/2006 | WO2006018024A2 Cosmetic and pharmaceutical compositions comprising ace inhibitors and/or angiotensin ii receptor antagonists |
| 02/23/2006 | WO2006009418A8 Method of obtaining cyanogenic glycosides and related glycosides, as well as genin and sapogenin derivatives of plants of the sapodilla family, for the preparation of cosmetics and dermatological compositions |
| 02/23/2006 | WO2005123094A3 Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones |
| 02/23/2006 | WO2005102319A3 Use of melatonin in preventing postoperative complications |
| 02/23/2006 | US20060041019 Inhibitor of anticancer drug side effect |
| 02/23/2006 | US20060040984 Novel piperidine derivatives for use in the treatment of chemokine medicated disease states |
| 02/23/2006 | US20060040956 Substituted alkylamine derivatives and methods of use |
| 02/23/2006 | US20060040933 Antiinflammatory agents |
| 02/23/2006 | US20060040912 Compounds for pdt |
| 02/23/2006 | US20060040876 Modulation of peroxisome proliferator-activated receptors |
| 02/23/2006 | US20060040850 Use of enzyme inhibitors with aminopeptidase n and/or dipeptidylpeptidase IV activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases with seborrhoeic hyperproliferation and altered differentiation states |
| 02/23/2006 | US20060040331 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 02/23/2006 | US20060040313 Human chemokine beta-9 |
| 02/23/2006 | US20060040265 Regulation of novel human asparagine-hydroxylases |
| 02/23/2006 | US20060039989 Pharmaceutical compositions of cell lysate and processes for the production and use thereof |
| 02/23/2006 | US20060039930 Methods for enhancing wound healing |
| 02/23/2006 | US20060039903 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 02/23/2006 | US20060039884 Baldness related gene and the polypeptide encoded thereby , and uses |
| 02/23/2006 | DE202005019455U1 Cosmetic or pharmaceutical mixture/agent, useful e.g. to treat acne and/or unclean skin, comprises extract or ethereal oils from spice plant such as thyme, marjoram, rosemary or sage |
| 02/23/2006 | DE20023745U1 Method of modulating expression of an endogenous cellular gene in a cell to prevent gene activation or prevent repression of gene expression comprising contacting a target sequence with a zinc finger protein |
| 02/23/2006 | CA2619779A1 Use of a pde5 inhibitor for treating and preventing hypopigmentary disorders |
| 02/23/2006 | CA2578529A1 Cosmetic and pharmaceutical compositions comprising ace inhibitors and/or angiotensin ii receptor antagonists |
| 02/23/2006 | CA2577274A1 Anti-inflammatory agents |
| 02/23/2006 | CA2575842A1 A composition containing a thiourea derivative for preventing or treating pruritic or irritant skin diseases |
| 02/23/2006 | CA2575787A1 Dihydropteridinones for the treatment of cancer diseases |
| 02/23/2006 | CA2575033A1 Novel biaromatic compounds that activate ppar type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 02/23/2006 | CA2575029A1 Novel biaromatic compounds which activate receptors of ppar type and their use in cosmetic or pharmaceutical compositions |
| 02/23/2006 | CA2573720A1 Netrin-related compositions and uses |
| 02/23/2006 | CA2573457A1 4-(2-methoxy-phenoxy)-2-trifluoromethyl-benzonitrile as an androgen modulator |
| 02/22/2006 | EP1627880A1 Boronic ester and acid compounds, synthesis and uses |
| 02/22/2006 | EP1627871A1 Cyclic aminophenyl sulfamate derivative |
| 02/22/2006 | EP1627870A1 Cyanofluoropyrrolidine derivative |
| 02/22/2006 | EP1627644A1 PREPARTAION FOR EXTERNAL PERCUTANEOUS ADMINISTRATION CONTAINING NON-STEROIDAL ANTI-INFLAMMATORY DRUG AND INTERLEUKIN-1a PRODUC TION INHIBITOR |
| 02/22/2006 | EP1626779A2 Topical treatment of sebum related skin conditions |
| 02/22/2006 | EP1626736A1 C1 inhibitor with short half-life for transient treatment |
| 02/22/2006 | EP1456210B1 Pyrazolyl-substituted triazoloquinoxalines |
| 02/22/2006 | EP1414812B1 Hydroxamic acid derivatives |
| 02/22/2006 | EP1385856B1 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method |
| 02/22/2006 | EP1385839B1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/22/2006 | EP1237874B1 Selective neurokinin antagonists |
| 02/22/2006 | EP0957929B1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes |
| 02/22/2006 | EP0814837B2 Use of g class immunoglobulins for the topical treatment of atopic dermatitis |
| 02/22/2006 | CN1738888A Antioxidant, skin preparation for external use, cosmetic and food |
| 02/22/2006 | CN1738827A Novel ampiphilic derivatives of alpha-c-phenyl n-tert-butyl nitrone |
| 02/22/2006 | CN1738806A Oxo-azabicyclic compounds |